The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
insulin lispro · Crystal
6 marketed package NDCs · 2 active manufacturers
Most dispensed: 100 [iU]/mL · Injection, Solution · #5 syringes/carton / 3 ml in 1 syringe · 100 [iU]/mL · Injection, Suspension · #5 syringes/carton / 3 ml in 1 syringe · 100 [iU]/mL · Injection, Solution · #1 vial/carton / 10 ml in 1 vial · 100 [iU]/mL · Injection, Solution · #5 cartridges/carton / 3 ml in 1 cartridge
What changed in the last 90 days
Every detected change for insulin lispro, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Insulin Lispro Junior KwikPenSep 3, 2026New shortageby this manufacturerEli Lilly and Co.'s Insulin Lispro Junior KwikPen (Injection, 100 [iU]/1 mL) is newly in shortage7 companies market insulin lispro junior kwikpen
- New shortageby this manufacturerEli Lilly and Co.'s Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen (Injection, 100 [iU]/1 mL) is newly in shortage7 companies market insulin lispro protamine and insulin lispro injectable suspension mix75/25 kwikpen
- AdmelogAug 19, 2026Price upNADAC $12.56633 → $12.56778 per unit (+0.01%)
- AdmelogAug 19, 2026Price downNADAC $12.11165 → $12.10525 per unit (-0.05%)
- AdmelogAug 19, 2026Price upNADAC $9.39259 → $9.39298 per unit (0%)
- Humalog KwikPenAug 19, 2026Price upNADAC $10.1691 → $10.1686 per unit (0%)
- Humalog Mix50/50 KwikPenAug 19, 2026Price downNADAC $10.14315 → $10.14259 per unit (-0.01%)
- Humalog Mix75/25 KwikPenAug 19, 2026Price upNADAC $10.16897 → $10.16999 per unit (+0.01%)
- Price upNADAC $10.19317 → $10.20056 per unit (+0.07%)
- Insulin Lispro KwikPenAug 19, 2026Price downNADAC $10.19923 → $10.19376 per unit (-0.05%)
Same drug class
Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- attention deficit mild drops· 1 maker
- attention deficit severe drops· 1 maker
- dna insulin drops· 1 maker
- insulin aspart injection· 1 maker
- insulin aspart-fsan· 1 maker
- insulin aspart-xjhz· 1 maker
- insulin degludec and liraglutide· 1 maker
- insulin glargine and lixisenatide· 1 maker
- insulin glargine-aldy· 1 maker
- insulin glulisine· 1 maker
- pancreas db liquescence· 1 maker
- insulin· 2 makers
Common questions
- Is Insulin lispro in shortage right now?
- No. FDA does not currently list Insulin lispro in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Insulin lispro?
- 7 companies have marketed Insulin lispro in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Insulin lispro cost?
- The typical pharmacy pays about $10.16 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.